Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05872464

Artificial Saliva Containing Cumin and Ginger Extract in Head and Neck Cancer Patients With Xerostomia

Efficacy and Safety of Artificial Saliva Containing Cumin and Ginger Extract in Head and Neck Cancer Patients With Xerostomia

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objectives of this study are to evaluate efficacy and safety of artificial saliva containing cumin and ginger extract in head and neck cancer patients with xerostomia.

Detailed description

There are 52 patients in this study. They are divided into 2 groups which are artificial saliva containing cumin and ginger extract group (test group) 26 patients and placebo group 26 patients. The patients spray the sample into the mouth 3 times/day for 14 day. Amount of saliva, pH of saliva, xerostomia questionnaires, WHO Oral Mucositis Grading Scale, quality of life, adverse events, and satisfaction were assessed.

Conditions

Interventions

TypeNameDescription
OTHERArtificial saliva containing cumin and ginger extractArtificial saliva containing cumin and ginger extract in spray bottle
OTHERPlaceboPlacebo containing composition close to the test group without cumin and ginger extract in spray bottle

Timeline

Start date
2024-07-01
Primary completion
2025-05-30
Completion
2025-06-30
First posted
2023-05-24
Last updated
2024-06-24

Source: ClinicalTrials.gov record NCT05872464. Inclusion in this directory is not an endorsement.